Sallie Bernard
From Wikipedia, the free encyclopedia
Sallie Bernard is a co-founder and the executive director of Safe Minds. She served as the board chairwoman for Cure Autism Now, one of the largest funders of research on biomedical therapies for autism spectrum disorders (now merged with Autism Speaks). Bernard is the founder and former president of ARC Research, a market research and marketing consulting firm, which she sold in 2004. She was also a member of the Founders Forum for The Autism Center of University of Medicine and Dentistry of New Jersey. Her son, Bill, has autism.
Bernard has testified before the House Government Reform Committee of the United States Congress, and has made a presentation before the Institute of Medicine. She has published a number of research papers and letters in science journals, and participates in several government committees addressing the adverse effects of mercury on neurodevelopment.
[edit] Education
Bernard graduated with honors from Radcliffe College, Harvard University, in 1979.
[edit] External links
- Bernard S, Enayati A, Redwood L, Roger H, Binstock T (2001). "Autism: a novel form of mercury poisoning". Med. Hypotheses 56 (4): 462–71. doi:. PMID 11339848.
- PRNewsWire.com (September 26, 2007). "Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds: "Study Findings and Limitations Require Further Investigations," Says Dissenting Panel Member". Press release. Retrieved on 2007-11-15.
- Sallie Bernard (June 10, 2003). Safe Minds Commentary on American Academy of Pediatricians Critique of Geier & Geier Thimerosal Paper. VaccinationNews.com. Retrieved on 2007-11-15.
- Bio from Safe Minds
|
|||||||||||||||||
